Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty

BACKGROUND: Triptorelin, a long-acting gonadotropin-releasing hormone (GnRH) agonist, is available in 1-, 3-, and 6-month formulations to treat central precocious puberty (CPP). The triptorelin pamoate 22.5-mg 6-month formulation recently approved for CPP offers greater convenience to children by re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Eunjoo, Kim, Sinae, Jung, Hye Lim, Shim, Jung Yeon, Shim, Jae Won, Kim, Deok Soo, Kwak, Ji Hee, Kim, Eun Sil, Yang, Aram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982112/
https://www.ncbi.nlm.nih.gov/pubmed/36875449
http://dx.doi.org/10.3389/fendo.2023.1134977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982112/
https://www.ncbi.nlm.nih.gov/pubmed/36875449
http://dx.doi.org/10.3389/fendo.2023.1134977

Ejemplares similares